We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$70.4M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$35.8M
3
PRF icon
Invesco FTSE RAFI US 1000 ETF
PRF
+$24M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$17.2M
5
BND icon
Vanguard Total Bond Market
BND
+$12.6M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXL
1326
DELISTED
EXCEL TRUST , INC COM STK
EXL
$181K 0.01%
+11,500
New +$181K
JCE icon
1327
Nuveen Core Equity Alpha Fund
JCE
$278M
$180K 0.01%
11,326
-1,333
-11% -$22.3K
ENZ
1328
DELISTED
Enzo Biochem, Inc.
ENZ
$180K 0.01%
59,502
+35,308
+146% +$99.3K
MANU icon
1329
Manchester United
MANU
$4.04B
$179K 0.01%
10,010
– –
OREX
1330
DELISTED
Orexigen Therapeutics, Inc.
OREX
$179K 0.01%
+3,612
New +$216K
EMD
1331
Western Asset Emerging Markets Debt Fund
EMD
$611M
$177K ﹤0.01%
11,834
– –
BCS icon
1332
Barclays
BCS
$93.4B
$175K ﹤0.01%
11,422
-1,120
-9% -$16.8K
FPL
1333
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$174K ﹤0.01%
11,122
+7
+0.1% +$119
LSTA icon
1334
Lisata Therapeutics
LSTA
$9.38M
$173K ﹤0.01%
615
+233
+61% +$86.6K
NSM
1335
DELISTED
Nationstar Mortgage Holdings
NSM
$173K ﹤0.01%
+10,300
New +$223K
BTA
1336
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$169K ﹤0.01%
15,640
– –
XNET
1337
Xunlei
XNET
$360M
$169K ﹤0.01%
14,000
– –
OIG
1338
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$169K ﹤0.01%
833
– –
SRF
1339
DELISTED
THE CUSHING ROYALTY & INCOME FUND
SRF
$169K ﹤0.01%
7,853
-1,362
-15% -$35K
IDE
1340
Voya Infrastructure, Industrials and Materials Fund
IDE
$196M
$168K ﹤0.01%
11,490
-71
-0.6% -$1.08K
JGH icon
1341
Nuveen Global High Income Fund
JGH
$352M
$168K ﹤0.01%
10,010
-10,373
-51% -$178K
JTD
1342
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
$168K ﹤0.01%
10,627
-4,373
-29% -$70.9K
SPPP
1343
Sprott Physical Platinum and Palladium Trust
SPPP
$587M
$167K ﹤0.01%
22,301
-158
-0.7% -$1.29K
CHI
1344
Calamos Convertible Opportunities and Income Fund
CHI
$999M
$165K ﹤0.01%
13,516
+1,106
+9% +$14.3K
NML
1345
Neuberger Energy Infrastructure and Income Fund Inc
NML
$583M
$165K ﹤0.01%
10,125
-72
-0.7% -$1.28K
FLY
1346
DELISTED
Fly Leasing Limited
FLY
$165K ﹤0.01%
+10,500
New +$160K
SGF
1347
DELISTED
Aberdeen Singapore Fund
SGF
$164K ﹤0.01%
14,797
– –
KMI.WS
1348
DELISTED
Kinder Morgan Inc
KMI.WS
$164K ﹤0.01%
60,741
+10,000
+20% +$40.9K
PRCP
1349
DELISTED
Perceptron Inc
PRCP
$161K ﹤0.01%
15,200
+1,250
+9% +$14.6K
UCFC
1350
DELISTED
United Community Financial Corp
UCFC
$161K ﹤0.01%
30,000
– –
52 53
54
55 56

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.